Analyst Articles

UPDATE REPORT – DCM – Double-Digit Quarterly Revenue Growth Continues Positive Business Momentum and Strong EBITDA in Q3/2023

We have written an 18-page Update Report on DATA Communications Management, a Canadian-based communications and marketing solutions provider that offers comprehensive online and offline communications and marketing solutions to businesses. The update report provides highlights of the Company’s Q3/2022 financials and a full summary of our valuation methodology. We increased the Target Price to $4.50 from $4.20. [more]

Analyst Articles

NEW INITIATION REPORT – Search Minerals – Critical Rare Earth Elements Exploration Company on a Path to Production to Capture NA Rare Earth Market

We have written a 72-page Initiation Report on Search Minerals, a mineral exploration and development company exploring and developing a Rare Earth Elements (REE) project in southeast Labrador and a REE Processing Plant in Newfoundland, Canada. The Company owns two advanced REE resources, Deep Fox and Foxtrot, along with regional prospects. As it “Sprints to Production”, the Company released an updated PEA report for the Deep Fox/Foxtrot project and is now working towards the start of a Feasibility Study with mining production targeted for C2025. [more]

2022-08-24 Kingsview - Initiation Report - FI2
Analyst Articles

NEW INITIATION REPORT – Kingsview Minerals – Exploring Golden Opportunities in the Wawa Gold Camp

We have written a 32-page Initiation Report on Kingsview Minerals, a Vancouver-based mineral exploration and development company that explores for gold and copper near Wawa, Ontario, Canada. The Company’s flagship project is the 100%-owned Echum Project covering an area of 7,691 hectares and an NI 43-101 technical report for the project was released on SEDAR in February 2022. It also holds a 100%-interest in the Hubcap Project in the same area, consisting of 4,163 hectares. [more]

Analyst Articles

6 Psychedelic-Treatment Clinic Stocks: An Overview

The size of the market for treatable mental health disorders is currently $300 billion in the U.S. and is expected to grow over the next five years. An opportunity exists for clinical-stage companies to commercialize their operations with alternative treatment methods to fill this need. The following article describes the commercialization developments, market capitalizations, and price performances of 6 companies in the industry. [more]